Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |